Evidence map›Paper›PMID 35948653›Full record

ArticleEuropean journal of pediatrics2022

Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19.

Aleksandra Stasiak, Ewelina Perdas, Elżbieta Smolewska

Open access · hybridAbstract read
In one paragraph

Article in European journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aleksandra StasiakDepartment of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Sporna 36/50 street, 91-738, Lodz, Poland. aleksandra.stasiak1@stud.umed.lodz.pl.ORCID http://orcid.org/0000-0002-8532-5140
Ewelina PerdasDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Elżbieta SmolewskaDepartment of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Sporna 36/50 street, 91-738, Lodz, Poland.ORCID http://orcid.org/0000-0002-8421-0448
Medical University of Lodz · PL

Funding

Uniwersytet Medyczny w Lodzi 503/8-000-01/503-81-001-19-00
6 · The paper itself

Abstract

Pediatric multi-system inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) is a serious complication of a previous SARS-CoV-2 infection. The disease causes multiple organ failure, but in some patients, a more severe course of the disease is observed. The treatment is multidirectional and depends on the severity and course of the disease, as some patients do not respond to the recommended treatment. The aim of this study was to identify laboratory risk factors affecting the more severe course of the disease and resistance to standard therapy. It is a single-center retrospective study considering 51 patients with PIMS-TS. Clinical features, laboratory results, and additional imaging tests data were taken into account. Fifty-one patients with PIMS-TS were hospitalized within a 16-month observation period. In the studied group, 26/51 children (51%) were girls. The mean age of patients was 7 years. Sex of the patient was not a risk factor for changes in cardiovascular system or severe course of the disease. Sixteen patients (31.3%) required transfer to the intensive care unit. Children with initially higher concentrations of NT-proBNP, troponin, creatinine, triglycerides, C-reactive protein, procalcitonin, ferritin, D-dimers and lower hematocrit, platelet count, lymphocytes, and ejection fraction should be strictly observed as they have a higher risk of severe course of the disease.

conclusionsLaboratory parameters especially markers of myocardial damage, markers of inflammation, blood count, as wells as biochemical parameters are significant risk indicators of severe course of PIMS -TS and their concentration can be defined as predictor of disease severity. WHAT IS KNOWN: • Pediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) is a serious complication of a previous SARS-CoV-2 infection in the group of pediatric patients • Course of the disease may be severe, which may cause long-term complications and the need for longitudinal patient care. WHAT IS NEW: • Children with higher concentrations of NT-proBNP, troponin, creatinine, TG, CRP, PCT, ferritin, D-dimers and lower hematocrit, PLT, lymphocytes, and EF have a higher risk of a severe course of the disease. • Patients with high concentration of NT-proBNP, troponin, CRP, lactates, ferritin, D-dimers, creatinine and a lower concentration of PLT, albumin, leukocytes; lymphopenia, hyponatremia are at risk for intravenous immunoglobulin resistance.

Indexed as

COVID-19ChildC-Reactive ProteinCreatinineFemaleFerritinsHumansImmunoglobulins, IntravenousLactatesMaleProcalcitoninRetrospective StudiesRisk FactorsSARS-CoV-2SyndromeSystemic Inflammatory Response SyndromeC-Reactive ProteinCreatinineFerritinsImmunoglobulins, IntravenousLactatesProcalcitoninTriglyceridesTroponinChildPIMSRisk factorsSARS-CoV-2

Identifiers

PMID35948653
PMCPMC9364844
OpenAlexW4290973252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.